Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen and nicotinamide.
Droller
M J
MJ
D002245:Carbon Dioxide / Q000627:therapeutic use*; D006801:Humans; D006931:Hyperbaric Oxygenation; D008920:Misonidazole / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use*; D010100:Oxygen / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy*
D011838:Radiation-Sensitizing Agents; D002245:Carbon Dioxide; D009536:Niacinamide; C011700:carbogen; D008920:Misonidazole; D010100:Oxygen